Despite Biden Promises, FDA Soundly Rejects Plan To Offer Pfizer Booster Shots

A group of advisors to the Food and Drug Administration on Friday reframed a proposed approval of BioNTech and Pfizer’s COVID-19 booster for the general population, and it instead recommended authorization of an additional dose of the vaccine to people at least 65 years old and those at high risk for severe disease. The decision to recommend a booster for older adults and at-risk people came after the FDA’s Vaccines and Related Biological Products Advisory Committee voted against a broader FDA approval of the BioNTech BNTX, -3.61% and Pfizer PFE, -1.30% booster for people who are at least 16 years old and vaccinated six months ago.

RELATED: FDA advisory panel votes against Pfizer boosters for all adults — after Biden promised it

Categories: Coronavirus, FDA, Joe Biden

Tagged as: , , ,

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s